APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Glargine

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Selected research

Industry Growth & Trends

Global Insulin Glargine Industry Growth and Trends Forecast to 2032

20 December 202578 pages

Choose your research edition.

Industry ResearchInsulin Glargine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Glargine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Insulin Glargine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Glargine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Glargine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.

USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.

Read the full market overview

In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

Report Scope

This report provides a structured, data-driven view of the global Insulin Glargine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Glargine market size, estimates, and forecasts are presented in terms of sales volume (M mL) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Glargine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Glargine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Glargine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Glargine Market by Company

Sanofi-Aventis

Ganlee

Biocon

Insulin Glargine Segment by Type

Single Dose Vial

Pre-filled Syringe

Insulin Glargine Segment by Application

Treat Type2 Diabetes

Treat Type1 Diabetes

Insulin Glargine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glargine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Glargine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glargine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Glargine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Dose Vial Table 2. Major Company of Pre-filled Syringe Table 3. Global Insulin Glargine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 5. Global Insulin Glargine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Insulin Glargine Sales Market Share in Value by Type (2021-2026) Table 8. Global Insulin Glargine Price by Type (2021-2026) & (USD/mL) Table 9. Global Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 10. Global Insulin Glargine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Insulin Glargine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Insulin Glargine Sales Market Share in Value by Type (2027-2032) Table 13. Global Insulin Glargine Price by Type (2027-2032) & (USD/mL) Table 14. North America Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 15. North America Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 17. Europe Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 19. Asia-Pacific Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 21. Latin America Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 23. Middle East and Africa Insulin Glargine Sales by Type (2021-2026) & (US$ Million) Table 24. Insulin Glargine Industry Trends Table 25. Insulin Glargine Industry Drivers Table 26. Insulin Glargine Industry Opportunities and Challenges Table 27. Insulin Glargine Industry Restraints Table 28. Global Insulin Glargine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Insulin Glargine Revenue Market Share by Company (2021-2026) Table 30. Global Insulin Glargine Sales by Company (2021-2026) & (M mL) Table 31. Global Insulin Glargine Sales Share by Company (2021-2026) Table 32. Global Insulin Glargine Market Price by Company (2021-2026) & (USD/mL) Table 33. Global Insulin Glargine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Insulin Glargine Major Company Production Sites and Headquarters Table 35. Global Insulin Glargine Company, Product Type & Application Table 36. Global Insulin Glargine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Insulin Glargine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Insulin Glargine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Insulin Glargine Sales by Region (2021-2026) & (M mL) Table 41. Global Insulin Glargine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Insulin Glargine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Insulin Glargine Sales Market Share in Value by Region (2021-2026) Table 44. Global Insulin Glargine Sales (M mL), Value (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 45. Global Insulin Glargine Sales by Region (2027-2032) & (M mL) Table 46. Global Insulin Glargine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Insulin Glargine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Insulin Glargine Sales Market Share in Value by Region (2027-2032) Table 49. Global Insulin Glargine Sales (M mL), Value (US$ Million), Price (USD/mL) and Gross Margin (2027-2032) Table 50. Global Insulin Glargine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 52. Global Insulin Glargine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Insulin Glargine Sales Market Share in Value by Application (2021-2026) Table 55. Global Insulin Glargine Price by Application (2021-2026) & (USD/mL) Table 56. Global Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 57. Global Insulin Glargine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Insulin Glargine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Insulin Glargine Sales Market Share in Value by Application (2027-2032) Table 60. Global Insulin Glargine Price by Application (2027-2032) & (USD/mL) Table 61. North America Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 62. North America Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 64. Europe Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 66. Asia-Pacific Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 68. Latin America Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 70. Middle East and Africa Insulin Glargine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi-Aventis Company Information Table 72. Sanofi-Aventis Business Overview Table 73. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 74. Sanofi-Aventis Insulin Glargine Product Portfolio Table 75. Sanofi-Aventis Recent Development Table 76. Ganlee Company Information Table 77. Ganlee Business Overview Table 78. Ganlee Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 79. Ganlee Insulin Glargine Product Portfolio Table 80. Ganlee Recent Development Table 81. Biocon Company Information Table 82. Biocon Business Overview Table 83. Biocon Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 84. Biocon Insulin Glargine Product Portfolio Table 85. Biocon Recent Development Table 86. North America Insulin Glargine Market Size Growth Rate (CAGR) by Country (M mL): 2021 VS 2025 VS 2032 Table 87. North America Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 88. North America Insulin Glargine Sales Market Share by Country (2021-2026) Table 89. North America Insulin Glargine Sales Forecast by Country (2027-2032) & (M mL) Table 90. North America Insulin Glargine Sales Market Share Forecast by Country (2027-2032) Table 91. North America Insulin Glargine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Insulin Glargine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Insulin Glargine Market Share by Country (2021-2026) Table 94. North America Insulin Glargine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Insulin Glargine Market Share Forecast by Country (2027-2032) Table 96. Europe Insulin Glargine Market Size Growth Rate (CAGR) by Country (M mL): 2021 VS 2025 VS 2032 Table 97. Europe Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 98. Europe Insulin Glargine Sales Market Share by Country (2021-2026) Table 99. Europe Insulin Glargine Sales Forecast by Country (2027-2032) & (M mL) Table 100. Europe Insulin Glargine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Insulin Glargine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Insulin Glargine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Insulin Glargine Market Share by Country (2021-2026) Table 104. Europe Insulin Glargine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Insulin Glargine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Insulin Glargine Market Size Growth Rate (CAGR) by Country (M mL): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 108. Asia-Pacific Insulin Glargine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Insulin Glargine Sales Forecast by Country (2027-2032) & (M mL) Table 110. Asia-Pacific Insulin Glargine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Insulin Glargine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Insulin Glargine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Insulin Glargine Market Share by Country (2021-2026) Table 114. Asia-Pacific Insulin Glargine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Insulin Glargine Market Share Forecast by Country (2027-2032) Table 116. Latin America Insulin Glargine Market Size Growth Rate (CAGR) by Country (M mL): 2021 VS 2025 VS 2032 Table 117. Latin America Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 118. Latin America Insulin Glargine Sales Market Share by Country (2021-2026) Table 119. Latin America Insulin Glargine Sales Forecast by Country (2027-2032) & (M mL) Table 120. Latin America Insulin Glargine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Insulin Glargine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Insulin Glargine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Insulin Glargine Market Share by Country (2021-2026) Table 124. Latin America Insulin Glargine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Insulin Glargine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Insulin Glargine Market Size Growth Rate (CAGR) by Country (M mL): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 128. Middle East and Africa Insulin Glargine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Insulin Glargine Sales Forecast by Country (2027-2032) & (M mL) Table 130. Middle East and Africa Insulin Glargine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Insulin Glargine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Insulin Glargine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Insulin Glargine Market Share by Country (2021-2026) Table 134. Middle East and Africa Insulin Glargine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Insulin Glargine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Insulin Glargine Distributors List Table 139. Insulin Glargine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Insulin Glargine Image Figure 2. Global Insulin Glargine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Glargine Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Glargine Sales (2021-2032) & (M mL) Figure 5. Single Dose Vial Image Figure 6. Global Single Dose Vial Sales YoY Growth (2021-2032) & (M mL) Figure 7. Pre-filled Syringe Image Figure 8. Global Pre-filled Syringe Sales YoY Growth (2021-2032) & (M mL) Figure 9. Global Insulin Glargine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Insulin Glargine Market Share by Type 2025 VS 2032 Figure 11. North America Insulin Glargine Sales Market Share in Volume by Type in 2025 Figure 12. North America Insulin Glargine Sales Market Share in Value by Type in 2025 Figure 13. Europe Insulin Glargine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Insulin Glargine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Insulin Glargine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Insulin Glargine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Insulin Glargine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Insulin Glargine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Insulin Glargine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Insulin Glargine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Insulin Glargine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Treat Type2 Diabetes Image Figure 24. Global Treat Type2 Diabetes Sales YoY Growth (2021-2032) & (M mL) Figure 25. Treat Type1 Diabetes Image Figure 26. Global Treat Type1 Diabetes Sales YoY Growth (2021-2032) & (M mL) Figure 27. Global Insulin Glargine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Insulin Glargine Market Share by Application 2025 VS 2032 Figure 29. North America Insulin Glargine Sales Market Share in Volume by Application in 2025 Figure 30. North America Insulin Glargine Sales Market Share in Value by Application in 2025 Figure 31. Europe Insulin Glargine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Insulin Glargine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Insulin Glargine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Insulin Glargine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Insulin Glargine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Insulin Glargine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Insulin Glargine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Insulin Glargine Sales Market Share in Value by Application in 2025 Figure 39. North America Insulin Glargine Sales by Country: 2021 VS 2025 VS 2032 (M mL) Figure 40. North America Insulin Glargine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Insulin Glargine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Insulin Glargine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Insulin Glargine Sales by Country: 2021 VS 2025 VS 2032 (M mL) Figure 44. Europe Insulin Glargine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Insulin Glargine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Insulin Glargine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Insulin Glargine Sales by Country: 2021 VS 2025 VS 2032 (M mL) Figure 48. Asia-Pacific Insulin Glargine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Insulin Glargine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Insulin Glargine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Insulin Glargine Sales by Country: 2021 VS 2025 VS 2032 (M mL) Figure 52. Latin America Insulin Glargine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Insulin Glargine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Insulin Glargine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Insulin Glargine Sales by Country: 2021 VS 2025 VS 2032 (M mL) Figure 56. Middle East and Africa Insulin Glargine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Insulin Glargine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Insulin Glargine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Insulin Glargine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Insulin Glargine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • Treat Type2 Diabetes
  • Treat Type1 Diabetes
Companies covered
  • Sanofi-Aventis
  • Ganlee
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Glargine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Glargine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Glargine Market by Type
  6. 1.3.1 Single Dose Vial
  7. 1.3.2 Pre-filled Syringe
  8. 1.4 Global Insulin Glargine Market Size by Type
  9. 1.4.1 Global Insulin Glargine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Insulin Glargine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Insulin Glargine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Insulin Glargine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Insulin Glargine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Insulin Glargine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Insulin Glargine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Insulin Glargine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Glargine Industry Trends
  2. 2.2 Insulin Glargine Industry Drivers
  3. 2.3 Insulin Glargine Industry Opportunities and Challenges
  4. 2.4 Insulin Glargine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Glargine Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Glargine Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Glargine Price (2021-2026)
  4. 3.4 Global Insulin Glargine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Glargine Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Glargine Company, Product Type & Application
  7. 3.7 Global Insulin Glargine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Glargine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Glargine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Glargine Tier 1, Tier 2, and Tier 3
4 Insulin Glargine Regional Status and Outlook
  1. 4.1 Global Insulin Glargine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Glargine Historic Market Size by Region
  3. 4.2.1 Global Insulin Glargine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Glargine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Glargine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Glargine Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Glargine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Glargine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Glargine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Glargine by Application
  1. 5.1 Insulin Glargine Market by Application
  2. 5.1.1 Treat Type2 Diabetes
  3. 5.1.2 Treat Type1 Diabetes
  4. 5.2 Global Insulin Glargine Market Size by Application
  5. 5.2.1 Global Insulin Glargine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Insulin Glargine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Insulin Glargine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Insulin Glargine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Insulin Glargine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Insulin Glargine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Insulin Glargine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Insulin Glargine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi-Aventis
  2. 6.1.1 Sanofi-Aventis Company Information
  3. 6.1.2 Sanofi-Aventis Business Overview
  4. 6.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi-Aventis Insulin Glargine Product Portfolio
  6. 6.1.5 Sanofi-Aventis Recent Developments
  7. 6.2 Ganlee
  8. 6.2.1 Ganlee Company Information
  9. 6.2.2 Ganlee Business Overview
  10. 6.2.3 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ganlee Insulin Glargine Product Portfolio
  12. 6.2.5 Ganlee Recent Developments
  13. 6.3 Biocon
  14. 6.3.1 Biocon Company Information
  15. 6.3.2 Biocon Business Overview
  16. 6.3.3 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biocon Insulin Glargine Product Portfolio
  18. 6.3.5 Biocon Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Glargine Sales by Country
  2. 7.1.1 North America Insulin Glargine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Glargine Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Glargine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Glargine Market Size by Country
  6. 7.2.1 North America Insulin Glargine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Glargine Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Glargine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Glargine Sales by Country
  2. 8.1.1 Europe Insulin Glargine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Glargine Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Glargine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Glargine Market Size by Country
  6. 8.2.1 Europe Insulin Glargine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Glargine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Glargine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Glargine Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Glargine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Glargine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Glargine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Glargine Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Glargine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Glargine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Glargine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Glargine Sales by Country
  2. 10.1.1 South America Insulin Glargine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Glargine Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Glargine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Glargine Market Size by Country
  6. 10.2.1 South America Insulin Glargine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Glargine Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Glargine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Glargine Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Glargine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Glargine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Glargine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Glargine Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Glargine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Glargine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Glargine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Glargine Value Chain Analysis
  2. 12.1.1 Insulin Glargine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Glargine Production Mode & Process
  7. 12.2 Insulin Glargine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Glargine Distributors
  10. 12.2.3 Insulin Glargine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst